30
Participants
Start Date
October 5, 2022
Primary Completion Date
December 1, 2025
Study Completion Date
December 1, 2025
Biopsy Procedure
Undergo biopsy
Biospecimen Collection
Undergo blood sample collection
Computed Tomography
Undergo CT scan
Echocardiography Test
Undergo echocardiography
Multigated Acquisition Scan
Undergo MUGA scan
Neratinib Maleate
Given PO
Trastuzumab Deruxtecan
Given IV
RECRUITING
University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
RECRUITING
University of Florida Health Science Center - Gainesville, Gainesville
RECRUITING
University of Kentucky/Markey Cancer Center, Lexington
RECRUITING
Ohio State University Comprehensive Cancer Center, Columbus
RECRUITING
University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
RECRUITING
University of Wisconsin Carbone Cancer Center - University Hospital, Madison
RECRUITING
Northwestern University, Chicago
RECRUITING
Washington University School of Medicine, St Louis
RECRUITING
M D Anderson Cancer Center, Houston
RECRUITING
City of Hope Comprehensive Cancer Center, Duarte
RECRUITING
City of Hope South Pasadena, South Pasadena
RECRUITING
City of Hope Upland, Upland
RECRUITING
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
RECRUITING
City of Hope at Irvine Lennar, Irvine
RECRUITING
UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
RECRUITING
City of Hope Antelope Valley, Lancaster
RECRUITING
University of California Davis Comprehensive Cancer Center, Sacramento
RECRUITING
Dana-Farber Cancer Institute, Boston
National Cancer Institute (NCI)
NIH